How Motorcycle OEM US Highland (OTC.BB: UHLN.PK) can Benefit from Industry Growth
October 25, 2011- Investorideas.com, a leader in sector research for independent investors issues a snapshot on the motorcycle industry and how the industry is showing signs of recovery, with better than expected sales from the industry leaders and how small player US Highland, Inc. (OTC.BB: UHLN.PK) can participate in the growth as an OEM supplier .
Motorcycle Industry Commentary
Randy Lewis, CFA, Founder of EquityNet Research
For full article, bio and full disclaimer: http://www.investorideas.com/news/2011/article/10251.asp
Overall sales are up about 10% this year from a year ago.
Harley Davidson (NYSE:HOG) and Polaris (NYSE:PII ) (which owns Indian and Victory Motorcycles), are the industry’s top guns, collectively owning well over 50% of the U.S. market.
Both companies (having recently reported Q3 earnings) have had strong rebounds and are showing phenomenal growth in an industry that is supposedly underwater. Polaris recently raised its sales growth outlook to 30% to 32% based on a solid – and better than expected - third quarter. Sales of off-road vehicles rose 25% and fueled significant market share gains by ATVs in the North American market. Sales of Victory Motorcycles were up 77% compared to figures from the same period last year. Even “Parts, Garments and Accessories” sales increased 21%.
Similar things are happening at Harley Davidson, though the company has run into some production issues. Sales of new motorcycles rose 5.1% to 61,838 bikes, which included a 5.4% increase in U.S. sales. This pushed revenue from bike sales and related products up 13.4% to $1.23 billion. Harley held its motorcycle shipment forecast steady for 2011, saying it still expects to ship between 8% to 12% more new bikes than last year (right in line with Jones’ 10% growth estimate).
Of course, sales of finished goods should also drive sales growth for OEMs that supply manufacturers. One such company, US Highland, Inc. (OTC.BB: UHLN.PK) is a relatively new player on the OEM scene, providing complete single cylinder and v-twin engine powertrain foundations - engine platforms coupled with patent-pending innovative fuel systems.
After its own challenges in an industry that has had its share, US Highland is in the midst of a restructuring, bringing in new management (now headed by Harley Davidson and Indian veteran, John Fitzpatrick) solidifying its strategy and operations, and working to raise capital to fund its business plan. Thus, we do not have a lot of specific information at this time, but we do know the Company appears to be an engineering and technology firm first. US Highland generated over $1.5 million in revenues last year from engineering and business development activities, but plans are to target OEM manufacturers, followed by its own line of motorcycles in 2012.
According to management, the Company is currently working with several OEMs for the implementation of its powertrain technology, the results of which could extend US Highland sales beyond 20,000 units per year globally.
For full article, bio and full disclaimer:
http://www.investorideas.com/news/2011/article/10251.asp
US Highland, Inc. (OTC.BB: UHLN.PK) is a US-based designer and manufacturer of high performance, premium quality powertrains. The Company is also a leading development and engineering partner for leading OEMs around the world. http://ushighland.com.
UHLN Company Contact:
John FitzpatrickCEO (918) 827-5254
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure : Investorideas.com has been compensated five thousand to advertise US Highland, Inc and distribute news releases and content on their behalf by a third party IR firm.
Randy Lewis has been compensated $400 by InvestorIdeas.com for writing this article. Mr. Lewis does not own shares of any of the companies mentioned in this article
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411 - Source – www.Investorideas.com
Tuesday, October 25, 2011
Solar Expert J. Peter Lynch Goes Bottom Fishing for Solar Stocks
Solar Stocks Commentary with J Peter Lynch
Read other articles, Exclusively for InvestorIdeas.com and Renewableenergystocks.com:
http://www.renewableenergystocks.com/PL/
Market Turning Positive Despite all the Terrible News
Over the past few days most of my indicators (technical) have turned positive and despite all the terrible news in the U.S. economy and in Europe what appears to be happening NOW is a buying opportunity.
There is an old saying that a rising tide lifts ALL boats.
The solar sector has literally been destroyed and NONE of the stocks in our solar stock list have given a strong buy signal - but I have gotten so many e-mails regarding what to buy if an investor wants to "bottom fish" in the solar area.
I took a look at the sector over the weekend and we "bought" (simulated, not actual) the following 5 solar stocks yesterday (10-24-2011) these are the best five stocks, in my opinion, if you want to take a chance and bottom fish in the solar industry sector. But keep in mind this is a trading play and should be classified as higher risk money.
We also further diversified, due to the weakness of the sector, by putting an equal amount of money ($5,000) into each stock, thereby not having the portfolio overly influenced by any one stock being overweighed and having a disproportional effect on the portfolio results.
Good Luck traders.....
Bottom Fisher Solar 5 Portfolio - 10/24/2011
Background Notes
Keep in mind that there are two basic types of equity (stock) analysis. Below are a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of a company to identify which stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy a stock or sell a stock.
Technical Analysis - this form of analysis will tell you "when" to buy a stock and when to sell the stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investorideas.com 800 665 0411
Email: dvanzant@investorideas.com
Peter Buys Five Solar Stocks: WFR, JASO, JKS, YGE, SOL
Point Roberts, South Salem, New York - October 25, 2011 www.Investorideas.com, a leader in renewable energy stock research for independent investors, releases solar stocks review from contributor, J. Peter Lynch, one of the most quoted solar experts during the recent Solyndra failure. Peter sees a bottom in the sector and goes long five well-known solar stocks; WFR, JASO, JKS, YGE, SOL.Solar Stocks Commentary with J Peter Lynch
Read other articles, Exclusively for InvestorIdeas.com and Renewableenergystocks.com:
http://www.renewableenergystocks.com/PL/
Market Turning Positive Despite all the Terrible News
Over the past few days most of my indicators (technical) have turned positive and despite all the terrible news in the U.S. economy and in Europe what appears to be happening NOW is a buying opportunity.
There is an old saying that a rising tide lifts ALL boats.
The solar sector has literally been destroyed and NONE of the stocks in our solar stock list have given a strong buy signal - but I have gotten so many e-mails regarding what to buy if an investor wants to "bottom fish" in the solar area.
I took a look at the sector over the weekend and we "bought" (simulated, not actual) the following 5 solar stocks yesterday (10-24-2011) these are the best five stocks, in my opinion, if you want to take a chance and bottom fish in the solar industry sector. But keep in mind this is a trading play and should be classified as higher risk money.
We also further diversified, due to the weakness of the sector, by putting an equal amount of money ($5,000) into each stock, thereby not having the portfolio overly influenced by any one stock being overweighed and having a disproportional effect on the portfolio results.
Good Luck traders.....
Bottom Fisher Solar 5 Portfolio - 10/24/2011
| Stock | Price | $$ Invest | Number of Shares |
| WFR | 6.05 | 5000 | 826 |
| JASO | 2.19 | 5000 | 2283 |
| JKS | 8.36 | 5000 | 598 |
| YGE | 3.71 | 5000 | 1347 |
| SOL | 2.19 | 5000 | 2283 |
Keep in mind that there are two basic types of equity (stock) analysis. Below are a brief description of each and its primary purpose:
Fundamental Analysis - this is the analysis of the fundamental financial condition of a company to identify which stocks you may want to buy when the timing is right. This form of analysis will give you NO indication of the best time to buy a stock or sell a stock.
Technical Analysis - this form of analysis will tell you "when" to buy a stock and when to sell the stock. It will do this by showing you (in chart format) the basic interaction of supply and demand and when the two change and shift which will indicate a time to buy or a time to sell.
Mr. Lynch has worked, for 34 years as a Wall Street security analyst, an independent security analyst an investment banker and private investor in small emerging technology companies. He has been actively involved in following developments in the renewable energy sector since 1977 and is regarded as an expert in this field. He was the contributing editor for 17 years to the Photovoltaic Insider Report, the leading publication in PV that was directed at industrial subscribers, such as major energy companies, utilities and governments around the world. He is currently a private investor and advisor to a number of companies. He can be reached via e-mail at: SOLARJPL@aol.com. Please visit his website for the promotion of solar energy - www.sunseries.net
About Investorideas.com - a leader in cleantech investor researchInvestorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Renewable energy stocks directory - research over 1300 stocks
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.aspVisit our green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or
www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites.
Learn more: www.InvestorIdeas.com/About/Disclaimer.asp , http://www.investorideas.com/About/News/Clientspecifics.asp
For more information contact Investorideas.com 800 665 0411
Email: dvanzant@investorideas.com
Direction of Motorcycle Stocks: Harley Davidson (NYSE:HOG), Polaris (NYSE:PII), US Highland (OTC.BB: UHLN.PK)
October 25, 2011 - Investorideas.com, a leader in sector research for independent investors issues a snapshot on the motorcycle industry and how the industry is showing signs of recovery, with better than expected sales from the industry leaders.
Snapshot of the Motorcycle Industry
Randy Lewis, CFA, Founder of EquityNet Research
For full article, bio and full disclaimer: http://www.investorideas.com/news/ 2011/article/10251.asp
Overall sales are up about 10% this year from a year ago.
Harley Davidson (NYSE:HOG) and Polaris (NYSE:PII) (which owns Indian and Victory Motorcycles), are the industry's top guns, collectively owning well over 50% of the U.S. market.
Both companies (having recently reported Q3 earnings) have had strong rebounds and are showing phenomenal growth in an industry that is supposedly underwater. Polaris recently raised its sales growth outlook to 30% to 32% based on a solid - and better than expected - third quarter. Sales of off-road vehicles rose 25% and fueled significant market share gains by ATVs in the North American market. Sales of Victory Motorcycles were up 77% compared to figures from the same period last year. Even "Parts, Garments and Accessories" sales increased 21%.
Similar things are happening at Harley Davidson, though the company has run into some production issues. Sales of new motorcycles rose 5.1% to 61,838 bikes, which included a 5.4% increase in U.S. sales. This pushed revenue from bike sales and related products up 13.4% to $1.23 billion. Harley held its motorcycle shipment forecast steady for 2011, saying it still expects to ship between 8% to 12% more new bikes than last year (right in line with Jones' 10% growth estimate).
Of course, sales of finished goods should also drive sales growth for OEMs that supply manufacturers. One such company, US Highland, Inc. (OTC.BB: UHLN.PK) is a relatively new player on the OEM scene, providing complete single cylinder and v-twin engine powertrain foundations - engine platforms coupled with patent-pending innovative fuel systems.
After its own challenges in an industry that has had its share, US Highland is in the midst of a restructuring, bringing in new management (now headed by Harley Davidson and Indian veteran, John Fitzpatrick) solidifying its strategy and operations, and working to raise capital to fund its business plan. Thus, we do not have a lot of specific information at this time, but we do know the Company appears to be an engineering and technology firm first. US Highland generated over $1.5 million in revenues last year from engineering and business development activities, but plans are to target OEM manufacturers, followed by its own line of motorcycles in 2012.
According to management, the Company is currently working with several OEMs for the implementation of its powertrain technology, the results of which could extend US Highland sales beyond 20,000 units per year globally.
For full article, bio and full disclaimer: http://www.investorideas.com/news/2011/article/10251.asp
US Highland, Inc. (OTC.BB: UHLN.PK) is a US-based designer and manufacturer of high performance, premium quality powertrains. The Company is also a leading development and engineering partner for leading OEMs around the world. http://ushighland.com.
UHLN Company Contact:
John FitzpatrickCEO (918) 827-5254
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Investorideas.com has been compensated five thousand to advertise US Highland, Inc and distribute news releases and content on their behalf by a third party IR firm.
Randy Lewis has been compensated $400 by InvestorIdeas.com for writing this article. Mr. Lewis does not own shares of any of the companies mentioned in this article
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
October 25, 2011 - Investorideas.com, a leader in sector research for independent investors issues a snapshot on the motorcycle industry and how the industry is showing signs of recovery, with better than expected sales from the industry leaders.
Snapshot of the Motorcycle Industry
Randy Lewis, CFA, Founder of EquityNet Research
For full article, bio and full disclaimer: http://www.investorideas.com/news/ 2011/article/10251.asp
Overall sales are up about 10% this year from a year ago.
Harley Davidson (NYSE:HOG) and Polaris (NYSE:PII) (which owns Indian and Victory Motorcycles), are the industry's top guns, collectively owning well over 50% of the U.S. market.
Both companies (having recently reported Q3 earnings) have had strong rebounds and are showing phenomenal growth in an industry that is supposedly underwater. Polaris recently raised its sales growth outlook to 30% to 32% based on a solid - and better than expected - third quarter. Sales of off-road vehicles rose 25% and fueled significant market share gains by ATVs in the North American market. Sales of Victory Motorcycles were up 77% compared to figures from the same period last year. Even "Parts, Garments and Accessories" sales increased 21%.
Similar things are happening at Harley Davidson, though the company has run into some production issues. Sales of new motorcycles rose 5.1% to 61,838 bikes, which included a 5.4% increase in U.S. sales. This pushed revenue from bike sales and related products up 13.4% to $1.23 billion. Harley held its motorcycle shipment forecast steady for 2011, saying it still expects to ship between 8% to 12% more new bikes than last year (right in line with Jones' 10% growth estimate).
Of course, sales of finished goods should also drive sales growth for OEMs that supply manufacturers. One such company, US Highland, Inc. (OTC.BB: UHLN.PK) is a relatively new player on the OEM scene, providing complete single cylinder and v-twin engine powertrain foundations - engine platforms coupled with patent-pending innovative fuel systems.
After its own challenges in an industry that has had its share, US Highland is in the midst of a restructuring, bringing in new management (now headed by Harley Davidson and Indian veteran, John Fitzpatrick) solidifying its strategy and operations, and working to raise capital to fund its business plan. Thus, we do not have a lot of specific information at this time, but we do know the Company appears to be an engineering and technology firm first. US Highland generated over $1.5 million in revenues last year from engineering and business development activities, but plans are to target OEM manufacturers, followed by its own line of motorcycles in 2012.
According to management, the Company is currently working with several OEMs for the implementation of its powertrain technology, the results of which could extend US Highland sales beyond 20,000 units per year globally.
For full article, bio and full disclaimer: http://www.investorideas.com/news/2011/article/10251.asp
US Highland, Inc. (OTC.BB: UHLN.PK) is a US-based designer and manufacturer of high performance, premium quality powertrains. The Company is also a leading development and engineering partner for leading OEMs around the world. http://ushighland.com.
UHLN Company Contact:
John FitzpatrickCEO (918) 827-5254
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Disclaimer/ Disclosure: The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: Investorideas.com has been compensated five thousand to advertise US Highland, Inc and distribute news releases and content on their behalf by a third party IR firm.
Randy Lewis has been compensated $400 by InvestorIdeas.com for writing this article. Mr. Lewis does not own shares of any of the companies mentioned in this article
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
Biotech/Biodefense Stock News; Aethlon Medical (OTCBB: AEMD) to Present at IN3 Medical Innovation Summit on October 27th
SAN DIEGO � October 25, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present a company overview, discuss recent developments and review upcoming milestones at the medical device partnering conference: Investment-In-Innovation (IN3) SUMMIT on October 27th in San Francisco, CA at the Intercontinental Mark Hopkins Hotel. IN3 events bring together early/mid/late-stage, medical technology innovators with investors, venture capitalists, and business development executives.
IN3 Summit is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. Leading venture capital firms and corporate acquirers are expected to attend to hear the latest innovations and investment opportunities.
About Aethlon Medical
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier® therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier® as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier® is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. For more information, please visit www.aethlonmedical.com.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
SAN DIEGO � October 25, 2011 (Investorideas.com newswire) - Aethlon Medical, Inc. (OTCBB: AEMD), the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announces that Chairman and CEO James A. Joyce will present a company overview, discuss recent developments and review upcoming milestones at the medical device partnering conference: Investment-In-Innovation (IN3) SUMMIT on October 27th in San Francisco, CA at the Intercontinental Mark Hopkins Hotel. IN3 events bring together early/mid/late-stage, medical technology innovators with investors, venture capitalists, and business development executives.
IN3 Summit is the largest annual strategic partnership and investment meeting for senior-level medical technology executives. Leading venture capital firms and corporate acquirers are expected to attend to hear the latest innovations and investment opportunities.
About Aethlon Medical
The Aethlon Medical mission is to create innovative devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. The Aethlon ADAPT™ system is an expansive technology platform that converges affinity drug agents and plasma membrane technology to create therapeutic filtration devices that selectively target the removal of harmful particles from the entire circulatory system. Our lead therapeutic candidate is the Aethlon Hemopurifier®, a device with broad-spectrum capabilities against viral pathogens and immunosuppressive cancer exosomes. In human studies, Hemopurifier® therapy has provided significant viral load reductions in HIV and hepatitis C virus infected individuals without the administration of antiviral drugs. We are now focused on advancing our Hemopurifier® as an adjunct strategy to improve the benefit of established infectious disease and cancer treatment regimens. Based on studies conducted by government and non-government research organizations, the Hemopurifier® is also a leading broad-spectrum treatment candidate to address bioterror and pandemic threats. For more information, please visit www.aethlonmedical.com.
Contacts:
James A. Joyce
Chairman, CEO
858.459.7800 x301
jj@aethlonmedical.com
Jody Cain
Senior Vice President, Lippert/Heilshorn & Associates
310.691.7100
jcain@lhai.com
Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com
John P. Salvador
Director, Communications & Investor Relations
858.459.7800 x307
jps@aethlonmedical.com
AETHLON MEDICAL INC (OTC BB: AEMD) is a Showcase biotech, biodefense and defense stock on Investorideas.com
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page
Disclosure/Disclaimer: AETHLON MEDICAL INC (OTC BB: AEMD) is a paid advertising client ($one thousand five hundred per month, $five thousand per month in 144 stock)
Visit the AETHLON MEDICAL INC (OTC BB: AEMD) showcase profile page
Monday, October 24, 2011
Clean Energy Stock Alert: Amtech Systems (NasdaqGS: ASYS) Trades Up over 20%
PointRoberts
, WA - October 24, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for Amtech Systems, Inc. (NasdaqGS: ASYS). The stock is trading up at $11.04, up 1.91 (20.92%) 2:28PM EDT. The stock is one of the top ten percentage gainers in today's trading.
About Amtech Systems, Inc.
Amtech Systems, Inc. manufactures capital equipment, including silicon wafer handling automation, thermal processing equipment and related consumables used in fabricating solar cells, LED and semiconductor devices. Semiconductors, or semiconductor chips, are fabricated on silicon wafer substrates, sliced from ingots, and are part of the circuitry, or electronic components, of many products including solar cells, computers, telecommunications devices, automotive products, consumer goods, and industrial automation and control systems. The Company's wafer handling, thermal processing and consumable products currently address the diffusion, oxidation, and deposition steps used in the fabrication of solar cells, semiconductors, MEMS and the polishing of LEDs and newly sliced silicon wafers.
Use the renewable energy stocks directory to research 1300 green stocks on global stock exchanges http://www.investorideas.com/Companies/ RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energystocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/ RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by ASYS
For more information about Investorideas.com contact:
800.665.0411
Point
About Amtech Systems, Inc.Amtech Systems, Inc. manufactures capital equipment, including silicon wafer handling automation, thermal processing equipment and related consumables used in fabricating solar cells, LED and semiconductor devices. Semiconductors, or semiconductor chips, are fabricated on silicon wafer substrates, sliced from ingots, and are part of the circuitry, or electronic components, of many products including solar cells, computers, telecommunications devices, automotive products, consumer goods, and industrial automation and control systems. The Company's wafer handling, thermal processing and consumable products currently address the diffusion, oxidation, and deposition steps used in the fabrication of solar cells, semiconductors, MEMS and the polishing of LEDs and newly sliced silicon wafers.
Use the renewable energy stocks directory to research 1300 green stocks on global stock exchanges http://www.investorideas.com/Companies/ RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/ RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by ASYS
For more information about Investorideas.com contact:
800.665.0411
Friday's NASDAQ Winners: TBOW, STX, SCSS, SYNA
POINT ROBERTS - October 24, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday October 21st. Nasdaq closed with a gain of +38.84 (+1.49%) at 2637.46.
Trunkbow International Holdings Ltd (NASDAQ:TBOW) was the top percentage gainer for the session closing higher 0.62 (31.00%) to $2.62, bouncing back from its 52-week low of $1.81, made on Oct 13, 2011. The stock has a 52-week range of $1.81-$5.25.
Seagate Technology PLC (NASDAQ:STX) surged 3.36 (27.86%) to $15.42 following the company reported better than estimated fiscal first quarter profit, but missed revenue estimates. The company reported profit of 34 cents a share, topping analysts' estimates by 3 cents a share. Also Thursday, Seagate said it believes it will close on the acquisition of hard disk drive assets from South Korea's Samsung by the end of the 2011.
The stock is up again in Monday's trading session .
Select Comfort Corp. (NASDAQ:SCSS) surged 1.31 (22.05%) to close at $7.25, extending its weekly gain to 32%. Recently, the company announced that it has received a Notice of Allowance from the UnitedStates Patent and Trademark Office for Application Serial No. 12/324808 entitled "Stable Compositions of Famotidine and Ibuprofen" with claims that cover DUEXIS(R).
Synaptics, Incorporated (NASDAQ:SYNA) closed with a gain of $5.16 (19.10%) to end the day at $32.18 after the company commented that its smartphone business has been growing at rapid pace and that would accelerate its gross margin going forward. Following this, analyst at Craig-Hallum upgraded the stock to Buy from Hold and upped their price target by $8 to $36. The stock has traded as high as $32.76 in Monday's morning trading.
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energystocks , biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
POINT ROBERTS - October 24, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday October 21st. Nasdaq closed with a gain of +38.84 (+1.49%) at 2637.46.
Trunkbow International Holdings Ltd (NASDAQ:TBOW) was the top percentage gainer for the session closing higher 0.62 (31.00%) to $2.62, bouncing back from its 52-week low of $1.81, made on Oct 13, 2011. The stock has a 52-week range of $1.81-$5.25.
Seagate Technology PLC (NASDAQ:STX) surged 3.36 (27.86%) to $15.42 following the company reported better than estimated fiscal first quarter profit, but missed revenue estimates. The company reported profit of 34 cents a share, topping analysts' estimates by 3 cents a share. Also Thursday, Seagate said it believes it will close on the acquisition of hard disk drive assets from South Korea's Samsung by the end of the 2011.
The stock is up again in Monday's trading session .
Select Comfort Corp. (NASDAQ:SCSS) surged 1.31 (22.05%) to close at $7.25, extending its weekly gain to 32%. Recently, the company announced that it has received a Notice of Allowance from the United
Synaptics, Incorporated (NASDAQ:SYNA) closed with a gain of $5.16 (19.10%) to end the day at $32.18 after the company commented that its smartphone business has been growing at rapid pace and that would accelerate its gross margin going forward. Following this, analyst at Craig-Hallum upgraded the stock to Buy from Hold and upped their price target by $8 to $36. The stock has traded as high as $32.76 in Monday's morning trading.
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
About www.InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
Defense and Security Stocks; UPSG (TSX-V: UZZ) Secures New Financing Facility
Edmonton, Alberta CANADA - October 24, 2011 (InvestorIdeas.com Newswire) - United Protection Security Group Inc. (TSX-V:UZZ Venture), F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. ("UPSG" or the "Company"), (TSX-V: UZZ) is pleased to announce that the Company has entered into a new receivables financing agreement with an international lender based in New York City. The new facility will allow the Company to pay out its existing lender and will also provide more working capital flexibility for planned growth.
The new facility limit will be $4.5M USD, compared to the $3M CAD limit the Company has with its current lender. The new facility does not impose any financial ratio covenants, and is secured by a corporate guarantee and also a by personal guarantee of the Chief Executive Officer of the Company. In consideration for the personal guarantee, the Company's board of directors has agreed to issue 8 million common shares at a price of $0.05 per share to Mr. Ramsoondar, subject to the closing of the transaction and approval of the TSX Venture Exchange. Upon the completion of this transaction Mr. Ramsoondar's shareholdings will exceed 15% of the total issued and outstanding shares of the Company.
The international lender also has term debt and equity financing facilities, which the Company will consider utilizing for its acquisition growth strategies.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
For additional investor and media relations inquiries contact:
Fredy Ramsoondar CEO and Director
Email: fredy.ramsoondar@unitedprotection.com
Tel: 780-465-8101
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/united10242011.htm
United Protection Security Group Inc. (TSX - V: UZZ)
5909 - 83rd Street, Edmonton, Alberta T6E 3Y4
Telephone (780) 465-8101
To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/unitedprotection09302011.htm
Source: United Protection Security Group Inc. (TSX-V: UZZ) http://www.unitedprotection.com
Maximum News Dissemination by Filing Services Canada Inc. http://www.usetdas.com
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
Edmonton, Alberta CANADA - October 24, 2011 (InvestorIdeas.com Newswire) - United Protection Security Group Inc. (TSX-V:UZZ Venture), F.V.Ramsoondar, Chief Executive Officer of United Protection Security Group Inc. ("UPSG" or the "Company"), (TSX-V: UZZ) is pleased to announce that the Company has entered into a new receivables financing agreement with an international lender based in New York City. The new facility will allow the Company to pay out its existing lender and will also provide more working capital flexibility for planned growth.
The new facility limit will be $4.5M USD, compared to the $3M CAD limit the Company has with its current lender. The new facility does not impose any financial ratio covenants, and is secured by a corporate guarantee and also a by personal guarantee of the Chief Executive Officer of the Company. In consideration for the personal guarantee, the Company's board of directors has agreed to issue 8 million common shares at a price of $0.05 per share to Mr. Ramsoondar, subject to the closing of the transaction and approval of the TSX Venture Exchange. Upon the completion of this transaction Mr. Ramsoondar's shareholdings will exceed 15% of the total issued and outstanding shares of the Company.
The international lender also has term debt and equity financing facilities, which the Company will consider utilizing for its acquisition growth strategies.
Stock Awareness Activities
To find out more about United Protection Security Group Inc. (TSX-V: UZZ), visit our website at www.unitedprotection.com. To join the 'request for information', go to the web page www.unitedprotection.com and click the tab 'request information' and follow the prompts.
For additional investor and media relations inquiries contact:
Fredy Ramsoondar CEO and Director
Email: fredy.ramsoondar@unitedprotection.com
Tel: 780-465-8101
Statements in this press release other than purely historical information, including statements relating to the Company's future plans and objectives or expected results, are forward-looking statements. Forward-looking statements are based on numerous assumptions and are subject to all of the risks and uncertainties inherent in the Company's business, including risks related to business development and retention, and risks related to the current economic and credit conditions. As a result, actual results may vary materially from those described in the forward-looking statements.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/united10242011.htm
United Protection Security Group Inc. (TSX - V: UZZ)
5909 - 83rd Street, Edmonton, Alberta T6E 3Y4
Telephone (780) 465-8101
To view this release as a web page, please click on the following link:
http://www.usetdas.com/pr/unitedprotection09302011.htm
Source: United Protection Security Group Inc. (TSX-V: UZZ) http://www.unitedprotection.com
Maximum News Dissemination by Filing Services Canada Inc. http://www.usetdas.com
Disclosure: UZZ is a paid advertising client on Investorideas.com and our defense portals.
Q&A Interview with CEO of BioSante Pharmaceuticals (NasdaqGM: BPAX) Following News of Positive LibiGel® Safety Data Review in Phase III Program
PointRoberts , WA - October 24, 2011- Investorideas.com, an investor research portal specializing in sector research including biotech and pharma stocks, issues an exclusive Q&A with Mr. Stephen M. Simes, President and Chief Executive Officer ofBioSante Pharmaceuticals, Inc. (NasdaqGM: BPAX).
The Company reported news earlier this month of positive LibiGel® safety data review in the Phase III program. Mr. Simes explains the significance of the data and what's next to take
LibiGel (testosterone gel) to market for the millions of women anxiously awaiting an approved FDA solution for female sexual dysfunction.
BioSante Pharmaceuticals Interview
Q: Investorideas.com
In the Company's last release, it was reported that "The DMC once again has recommended that the safety study continue as per the FDA-agreed protocol, without modification as there were no general or specific safety issues based on their unblinded review of adverse events."
Based on competitors dropping out of the market due to lack of sufficient safety data how significant is it that BioSante has reached this stage?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
Very significant. BioSante is conducting the largest safety study ever undertaken for a drug in the treatment of female sexual dysfunction. We are in the fourth year of a cardiovascular event and breast cancer safety study having completed enrollment at 3,656 women equally randomized to LibiGel or placebo. The Independent data monitoring committee has recommended continuing the study as per FDA-agreed protocol based on their seventh unblinded review of all safety data. We expect to be able to demonstrate the safety of LibiGel for the treatment of female sexual dysfunction.
Q: Investorideas.com
Can you explain to investors the next steps prior to filing an NDA in 2012?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We now have completed two LibiGel Phase III efficacy trials of over 500 women each. We expect to announce top-line efficacy data in December of this year. The LibiGel safety study will undergo its primary safety analysis next summer which will put us in position to submit the new drug application (NDA) by the end of 2012. Bases on positive safety and efficacy data we hope to receive FDA approval by mid-2013.
Q: Investorideas.com
LibiGel is currently the only product in Phase III clinical development for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), with an estimated market of $2 billion. How does the Company see the revenue stream following FDA approval?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We expect that the market for the treatment of female sexual dysfunction will be over $2 billion, which is the size of the erectile dysfunction market in the U.S. Based on published reports we believe the market for FSD will be at least that large. In addition, in 2010, there were about four million testosterone prescriptions written off-label for women, and in primary research doctors tell us they will switch over 90 percent of the off-label use to an FDA approved product.
Q: Investorideas.com
Several analysts including Rodman & Renshaw have a 12- month price target of $5.00 or more on the stock. The stock has had a 52-wwek high of just over $4.00 and has fallen back… What do you say to that?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
These are very difficult times in the market and in the economy. We believe our stock price is not reflecting accurately our true value. As we continue to make progress we would expect our stock price to reflect our true value. Happily we are in a very solid cash position with over $73 million in cash as of August 31, 2010 with an approximate $4 million/month burn rate which should decrease to about $3 million/month in 2012.
About LibiGel ®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy. The completed efficacy trials were conducted according to an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the UnitedStates , in surgically menopausal women distressed by their low sexual desire and activity.
About BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
or revise any forward-looking statement, whether as a result of new information, future events or otherwise. To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to its future operations and products, the timing of anticipated clinical development milestones and regulatory submissions and other statements identified by words such as "will," "could," "believes," "intends," "continue," "plans," "expects," "anticipates," "may," other words of similar meaning, derivatives of such words and the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update
For more information, please contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953 tswanson@troutgroup.com
For Media:
Harris D. McKinney, Inc.
Alan Zachary
(312) 506-5220 azachary@harrisdmckinney.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sectors. Sectors we cover include; water stocks, gold and mining stocks, China stocks, oil and gas stocks, renewable energy stocks, coal stocks, tech stocks, biotech stocks, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. BioSante is a paid advertising biotech stock on Investorideas.com (six thousand five hundred for three months)
Source - Investorideas.com 800-665-0411
Point
The Company reported news earlier this month of positive LibiGel® safety data review in the Phase III program. Mr. Simes explains the significance of the data and what's next to take
LibiGel (testosterone gel) to market for the millions of women anxiously awaiting an approved FDA solution for female sexual dysfunction.
BioSante Pharmaceuticals Interview
Q: Investorideas.com
In the Company's last release, it was reported that "The DMC once again has recommended that the safety study continue as per the FDA-agreed protocol, without modification as there were no general or specific safety issues based on their unblinded review of adverse events."
Based on competitors dropping out of the market due to lack of sufficient safety data how significant is it that BioSante has reached this stage?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
Very significant. BioSante is conducting the largest safety study ever undertaken for a drug in the treatment of female sexual dysfunction. We are in the fourth year of a cardiovascular event and breast cancer safety study having completed enrollment at 3,656 women equally randomized to LibiGel or placebo. The Independent data monitoring committee has recommended continuing the study as per FDA-agreed protocol based on their seventh unblinded review of all safety data. We expect to be able to demonstrate the safety of LibiGel for the treatment of female sexual dysfunction.
Q: Investorideas.com
Can you explain to investors the next steps prior to filing an NDA in 2012?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We now have completed two LibiGel Phase III efficacy trials of over 500 women each. We expect to announce top-line efficacy data in December of this year. The LibiGel safety study will undergo its primary safety analysis next summer which will put us in position to submit the new drug application (NDA) by the end of 2012. Bases on positive safety and efficacy data we hope to receive FDA approval by mid-2013.
Q: Investorideas.com
LibiGel is currently the only product in Phase III clinical development for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), with an estimated market of $2 billion. How does the Company see the revenue stream following FDA approval?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
We expect that the market for the treatment of female sexual dysfunction will be over $2 billion, which is the size of the erectile dysfunction market in the U.S. Based on published reports we believe the market for FSD will be at least that large. In addition, in 2010, there were about four million testosterone prescriptions written off-label for women, and in primary research doctors tell us they will switch over 90 percent of the off-label use to an FDA approved product.
Q: Investorideas.com
Several analysts including Rodman & Renshaw have a 12- month price target of $5.00 or more on the stock. The stock has had a 52-wwek high of just over $4.00 and has fallen back… What do you say to that?
A: Stephen M. Simes, President and Chief Executive Officer of BioSante Pharmaceuticals
These are very difficult times in the market and in the economy. We believe our stock price is not reflecting accurately our true value. As we continue to make progress we would expect our stock price to reflect our true value. Happily we are in a very solid cash position with over $73 million in cash as of August 31, 2010 with an approximate $4 million/month burn rate which should decrease to about $3 million/month in 2012.
About LibiGel ®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy. The completed efficacy trials were conducted according to an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In a Phase II trial, LibiGel significantly increased the number of satisfying sexual events in surgically menopausal women suffering from FSD by 238 percent versus baseline (p<0.0001); this increase also was significant versus placebo (p<0.05). In this study, the effective dose of LibiGel produced testosterone blood levels within the normal range for pre-menopausal women and had a safety profile similar to that observed in the placebo group. In addition, no serious adverse events and no discontinuations due to adverse events occurred in any subject receiving LibiGel. The Phase II clinical trial was a double-blind, placebo-controlled trial, conducted in the United
About BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX)
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel ® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
or revise any forward-looking statement, whether as a result of new information, future events or otherwise. To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to its future operations and products, the timing of anticipated clinical development milestones and regulatory submissions and other statements identified by words such as "will," "could," "believes," "intends," "continue," "plans," "expects," "anticipates," "may," other words of similar meaning, derivatives of such words and the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update
For more information, please contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953 tswanson@troutgroup.com
For Media:
Harris D. McKinney, Inc.
Alan Zachary
(312) 506-5220 azachary@harrisdmckinney.com
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sectors. Sectors we cover include; water stocks, gold and mining stocks, China stocks, oil and gas stocks, renewable energy stocks, coal stocks, tech stocks, biotech stocks, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. BioSante is a paid advertising biotech stock on Investorideas.com (six thousand five hundred for three months)
Source - Investorideas.com 800-665-0411
Oil and Gas Drilling Plans for the Mississippian: (OTCBB: OEDV), (NasdaqGM: RAM), (NYSE: RRC), (NYSE: SD)
Point Roberts, WA - October 24, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research for independent investors including oil and gas stocks, issues an update on publicly traded oil and gas stocks reporting drilling plans for the Mississippian Formation for the fourth quarter and into 2012.
Sandridge Energy Inc. (NYSE: SD) raised investor awareness to the significance of the Mississippian Formation play when it announced in August it entered into a joint venture with an affiliate of Atinum Partners Co., Ltd., an investment firm in the Republic of Korea. According to the agreement, SandRidge will transfer a 13.2% non-operated working interest in approximately 860,000 acres, or approximately 113,000 net acres to Atinum for $500 million.
Osage Exploration and Development, Inc. ( OTCBB: OEDV) noted in its September release, when the Company also reported an increase in its net acreage to 15,000 acres: “Slawson Exploration as Operator is focused on drilling the project in the fourth quarter this year, yet is bringing a tremendous amount of leadership to the land acquisition process as well. The synergy that has been created by the contribution of U.S. Energy on the land side, coupled with Slawson's and our own efforts, has increased the overall acquisition efficiency dramatically from my perspective," stated Kim Bradford, Chairman and CEO.
Slawson Exploration Company is the Operator of the project and owns 45%, U.S. Energy Development Corporation owns 30%, and Osage Exploration has 25%.
RAM Energy Resources, Inc (NasdaqGM: RAM ) reported in a recent update it is tentatively planning to drill its first horizontal Mississippi well in early 2012. The processing and interpretation of the company's Phase II seismic survey, which covers 31 square miles of the concession to the south and east of the 25 square-mile Phase I survey, is complete. The identification of potential new drilling locations over the Phase II survey is beginning, setting the stage for future drilling.
Range Resources Corporation (NYSE: RRC) reported to shareholders that leasing activity expanded during the quarter in the Mississippian horizontal play of northern Oklahoma. Having started the year with 15,000 net acres, Range's position has increased to over 92,000 net acres. Reserve projections are estimated in the range of 400-500 MBOE per well for approximately 2,000 foot laterals at depths of 5,000 feet. These potential reserves generate attractive finding and development costs, along with strong rates of return in this liquids-rich play. Range's production from the Mississippi horizontal area continues to hold at 3,400 gross (2,709 net) BOE per day. With its larger acreage position, Range is targeting a two rig drilling program in 2012 and is currently focused on adding the necessary infrastructure to facilitate future development
Sandridge Energy Inc. (NYSE: SD ), the most dominant player in the Mississippian Play, previously told Investorideas.com, "As far as our drilling plans for 2011, our capital plan has us drilling about 140 producers in the Mississippian.". Sandridge recently sold $231 Million in assets in its East Texas natural gas properties to focus on its core plays including the Mississippian.
This asset sale is part of the capital plan to execute our 3 Year Strategy of tripling EBITDA, doubling oil production, and lowering our debt ratio by the end of 2014 by continuing to develop high rate of return oil wells in the Central Basin Platform and the Mississippian play in the Mid-Continent."
More about Osage:
Osage Exploration and Development, Inc. ( OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Visit the Osage (OTCBB: OEDV) company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com – lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
800-665-0411
Source - Investorideas.com
Point Roberts, WA - October 24, 2011 (Investorideas.com Energy Newswire) - www.InvestorIdeas.com, a leader in sector research for independent investors including oil and gas stocks, issues an update on publicly traded oil and gas stocks reporting drilling plans for the Mississippian Formation for the fourth quarter and into 2012.
Sandridge Energy Inc. (NYSE: SD) raised investor awareness to the significance of the Mississippian Formation play when it announced in August it entered into a joint venture with an affiliate of Atinum Partners Co., Ltd., an investment firm in the Republic of Korea. According to the agreement, SandRidge will transfer a 13.2% non-operated working interest in approximately 860,000 acres, or approximately 113,000 net acres to Atinum for $500 million.
Osage Exploration and Development, Inc. ( OTCBB: OEDV) noted in its September release, when the Company also reported an increase in its net acreage to 15,000 acres: “Slawson Exploration as Operator is focused on drilling the project in the fourth quarter this year, yet is bringing a tremendous amount of leadership to the land acquisition process as well. The synergy that has been created by the contribution of U.S. Energy on the land side, coupled with Slawson's and our own efforts, has increased the overall acquisition efficiency dramatically from my perspective," stated Kim Bradford, Chairman and CEO.
Slawson Exploration Company is the Operator of the project and owns 45%, U.S. Energy Development Corporation owns 30%, and Osage Exploration has 25%.
RAM Energy Resources, Inc (NasdaqGM: RAM ) reported in a recent update it is tentatively planning to drill its first horizontal Mississippi well in early 2012. The processing and interpretation of the company's Phase II seismic survey, which covers 31 square miles of the concession to the south and east of the 25 square-mile Phase I survey, is complete. The identification of potential new drilling locations over the Phase II survey is beginning, setting the stage for future drilling.
Range Resources Corporation (NYSE: RRC) reported to shareholders that leasing activity expanded during the quarter in the Mississippian horizontal play of northern Oklahoma. Having started the year with 15,000 net acres, Range's position has increased to over 92,000 net acres. Reserve projections are estimated in the range of 400-500 MBOE per well for approximately 2,000 foot laterals at depths of 5,000 feet. These potential reserves generate attractive finding and development costs, along with strong rates of return in this liquids-rich play. Range's production from the Mississippi horizontal area continues to hold at 3,400 gross (2,709 net) BOE per day. With its larger acreage position, Range is targeting a two rig drilling program in 2012 and is currently focused on adding the necessary infrastructure to facilitate future development
Sandridge Energy Inc. (NYSE: SD ), the most dominant player in the Mississippian Play, previously told Investorideas.com, "As far as our drilling plans for 2011, our capital plan has us drilling about 140 producers in the Mississippian.". Sandridge recently sold $231 Million in assets in its East Texas natural gas properties to focus on its core plays including the Mississippian.
This asset sale is part of the capital plan to execute our 3 Year Strategy of tripling EBITDA, doubling oil production, and lowering our debt ratio by the end of 2014 by continuing to develop high rate of return oil wells in the Central Basin Platform and the Mississippian play in the Mid-Continent."
More about Osage:
Osage Exploration and Development, Inc. ( OTCBB: OEDV)
Based in San Diego, California with production offices in Oklahoma City, Oklahoma, and executive offices in Bogotá, Colombia, Osage Exploration and Development, Inc. is an independent exploration and production company with interests in oil and gas wells and prospects in the US and Colombia. www.osageexploration.com
Follow (OTCBB: OEDV) on Twitter.com
http://twitter.com/#!/OsageOEDV
Visit the Osage (OTCBB: OEDV) company showcase profile at Investorideas.com
http://www.investorideas.com/CO/OEDV/
Request news and trading alerts on OEDV
http://www.investorideas.com/Resources/Newsletter.asp
Research more oil and gas stocks with the oil and gas stock directory at Investorideas.com – lists over 600 stocks including Bakken stocks
http://www.investorideas.com/OGSN/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Investorideas.com is a third party publisher of news and research .Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Disclosure: OEDV is a paid advertising oil and gas company on Investorideas.com - Disclosure: (6 months starting May 24, 2011 thirty five hundred per month, 100,000 144 shares)
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp
800-665-0411
Source - Investorideas.com
Friday, October 21, 2011
Nanotech Stocks to Watch: AONE, MMM, ABB, ACCL
POINT ROBERTS, October 21, 2011 –Investorideas.com, a leader in sector research for independent investors including nanotechnology stocks , reports it has updated its global nanotech stock directory for investors following the sector. The directory features biotech, energy. defense, water and tech stocks utilizing advanced nanotechnology.
Featured Nanotechnology Stock
mPhase Technologies, Inc. (OTCBB: XDSL)
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and micro fluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Directory Preview
3M Co. (NYSE:MMM) 3M scientists and researchers are exploring a new world at the nanometer level, where materials exhibit unique physical, chemical and biological properties. These unusual properties are already being exploited in our hard coatings, dental restoratives and brightness-enhancing optical films (used in LCD displays). Many 3M technology platforms, including adhesives and pharmaceuticals, are being influenced by the emergence of nano-sized particles.
A123 Systems, Inc. (NasdaqGM:AONE) develops and manufactures advanced lithium-ion batteries and battery systems for the transportation, electric grid services and consumer markets. Founded in 2001 and headquartered in Massachusetts, A123 Systems' proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.
ABB Ltd. (NYSE:ABB) is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB group of companies operates in some 100 countries and employs approximately 120,000 people. Nanotech R&D: Nano-designed dielectrics can be engineered to an exact specification with an improved response to changing electric fields. This opens up the possibilities for cables, bushings, surge arresters and insulating materials. At the same time ABB is perfecting a nano-structured sliding bearing that works in MV and HV switchgear without oil, offering lower operating costs and less environmental impact.
Accelrys ( NasdaqGM:ACCL) is a Scientific Informatics software and services company for life sciences, chemical and materials R&D. We enable our customers to both accelerate their research process to more rapidly discover new therapeutics, materials and compounds; and to introduce new efficiencies into the process that drive lower costs The MesoProp is a new research tool which is used to predict the bulk properties of multicomponent nanostructured materials systems. The research applications for MesoProp include studies of polymers, surfactants and continuous phases which are fundamental to the development of surface coatings, adhesives, sealants, elastomers, cements, composite materials, gels, and laminates.
Altair Nanotechnologies (NasdaqCM:ALTI) is a leading provider of fast response battery systems technology. Altairnano's lithium-titanate based battery systems are among the highest performing in the world, and are used primarily to provide regulation and renewable integration in the areas of mass transit and stationary power. Altairnano is the first company to replace traditional graphite materials used in conventional lithium-ion batteries with a proprietary, nano-structured lithium titanate.
AMAG Pharmaceuticals, Inc. (NASDAQGM:AMAG) is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. AMAG's core technology is based on the characteristic properties of extremely small, coated superparamagnetic iron oxide nanoparticles.
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/Stocks_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
mPhase Technologies, Inc. (XDSL.OB) is a paid showcase nanotech advertising company on Investorideas.com ( fifteen hundred three months)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
To be added to the directory call
800-665-0411
POINT ROBERTS, October 21, 2011 –Investorideas.com, a leader in sector research for independent investors including nanotechnology stocks , reports it has updated its global nanotech stock directory for investors following the sector. The directory features biotech, energy. defense, water and tech stocks utilizing advanced nanotechnology.
Featured Nanotechnology Stock
mPhase Technologies, Inc. (OTCBB: XDSL)
mPhase Technologies is introducing a revolutionary Smart Surface technology enabled by breakthroughs in nanotechnology, MEMS processing and micro fluidics. Our Smart Surface technology has potential applications within drug delivery systems, lab-on-a-chip analytic systems, self-cleaning systems, liquid and chemical sensor systems, and filtration systems. mPhase has pioneered its first Smart Surface enabled product, the mPhase Smart NanoBattery.
In addition to the Smart Surface technology, mPhase recently introduced its first product, the mPower Emergency Illuminator, an award-winning product designed by Porsche Design Studio and sold via the mPower website: http://www.mpowertech.com. More information about the company can be found at http://www.mPhaseTech.com.
Directory Preview
3M Co. (NYSE:MMM) 3M scientists and researchers are exploring a new world at the nanometer level, where materials exhibit unique physical, chemical and biological properties. These unusual properties are already being exploited in our hard coatings, dental restoratives and brightness-enhancing optical films (used in LCD displays). Many 3M technology platforms, including adhesives and pharmaceuticals, are being influenced by the emergence of nano-sized particles.
A123 Systems, Inc. (NasdaqGM:AONE) develops and manufactures advanced lithium-ion batteries and battery systems for the transportation, electric grid services and consumer markets. Founded in 2001 and headquartered in Massachusetts, A123 Systems' proprietary nanoscale electrode technology is built on initial developments from the Massachusetts Institute of Technology.
ABB Ltd. (NYSE:ABB) is a leader in power and automation technologies that enable utility and industry customers to improve performance while lowering environmental impact. The ABB group of companies operates in some 100 countries and employs approximately 120,000 people. Nanotech R&D: Nano-designed dielectrics can be engineered to an exact specification with an improved response to changing electric fields. This opens up the possibilities for cables, bushings, surge arresters and insulating materials. At the same time ABB is perfecting a nano-structured sliding bearing that works in MV and HV switchgear without oil, offering lower operating costs and less environmental impact.
Accelrys ( NasdaqGM:ACCL) is a Scientific Informatics software and services company for life sciences, chemical and materials R&D. We enable our customers to both accelerate their research process to more rapidly discover new therapeutics, materials and compounds; and to introduce new efficiencies into the process that drive lower costs The MesoProp is a new research tool which is used to predict the bulk properties of multicomponent nanostructured materials systems. The research applications for MesoProp include studies of polymers, surfactants and continuous phases which are fundamental to the development of surface coatings, adhesives, sealants, elastomers, cements, composite materials, gels, and laminates.
Altair Nanotechnologies (NasdaqCM:ALTI) is a leading provider of fast response battery systems technology. Altairnano's lithium-titanate based battery systems are among the highest performing in the world, and are used primarily to provide regulation and renewable integration in the areas of mass transit and stationary power. Altairnano is the first company to replace traditional graphite materials used in conventional lithium-ion batteries with a proprietary, nano-structured lithium titanate.
AMAG Pharmaceuticals, Inc. (NASDAQGM:AMAG) is a biopharmaceutical company that utilizes its proprietary technology for the development and commercialization of a therapeutic iron compound to treat anemia and novel imaging agents to aid in the diagnosis of cancer and cardiovascular disease. AMAG's core technology is based on the characteristic properties of extremely small, coated superparamagnetic iron oxide nanoparticles.
Get the global stock directory of publicly traded nanotech stocks
http://www.investorideas.com/Nanotechnology/Stocks_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Learn More about Investorideas.com Nanotech showcase stocks
http://www.investorideas.com/Nanotechnology/
Sign up for the free investor news and hot stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas – Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
mPhase Technologies, Inc. (XDSL.OB) is a paid showcase nanotech advertising company on Investorideas.com ( fifteen hundred three months)
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source – Investorideas.com
To be added to the directory call
800-665-0411
Subscribe to:
Posts (Atom)